BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28282104)

  • 1. Retrospective Analysis of Emerging Drugs Use in a Quebec Women's and Children's University Hospital and Perspectives for Safe and Optimal Drug Use.
    Corny J; Pelletier E; Lebel D; Bussières JF
    J Popul Ther Clin Pharmacol; 2017 Mar; 24(1):e56-e64. PubMed ID: 28282104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
    Palčevski G; Skočibušić N; Vlahović-Palčevski V
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
    Borges AP; Campos MS; Pereira LR
    Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
    Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
    Jobanputra N; Save SU; Bavdekar SB
    Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
    Ellul IC; Grech V; Attard-Montalto S
    Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlicensed and off-label prescription of drugs to children in primary health care: A systematic review.
    Andrade SRA; Santos PANM; Andrade PHS; da Silva WB
    J Evid Based Med; 2020 Nov; 13(4):292-300. PubMed ID: 33047516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V; Lifshitz M; Levy J; Gorodischer R
    Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
    Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
    Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric off-label drug use in China: risk factors and management strategies.
    Zhang L; Li Y; Liu Y; Zeng L; Hu D; Huang L; Chen M; Lv J; Yang C
    J Evid Based Med; 2013 Feb; 6(1):4-18. PubMed ID: 23557523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of unlicensed and off-label prescription in children.
    Langerová P; Vrtal J; Urbánek K
    Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
    Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
    Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
    García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
    An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
    Aamir M; Khan JA; Shakeel F; Asim SM
    Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.